The company tripled sales to non-federal customers, effectively transitioning from a single-customer, single-product entity ...

Beam Therapeutics has presented the first clinical data on its base editing technology. All four sickle cell disease patients in the efficacy cohort had fetal hemoglobin levels above Beam’s target—and ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the stocks that could 10x over the next 5 years. On March 3, H.C. Wainwright ...

Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in early-to-mid-stage development for treating certain hematology and genetic diseases. The ...

Light, as we usually conceive of it, is defined by the astonishing velocity at which it moves from one point to another. For example, in just one second, light can travel most of the distance between ...